Keyphrases
Clinical Trials
100%
Drug Development
100%
Risk Outcomes
100%
Patient Outcomes
100%
Patient Benefit
100%
Risk-benefit
100%
Patient Risk
100%
Enzalutamide
100%
Adverse Events
33%
Objective Response
33%
Overall Survival
22%
Histology
22%
Approved Indication
22%
Data Extraction
11%
Inclusion Criteria
11%
PubMed
11%
Significant Benefit
11%
Embase
11%
Solid Tumors
11%
Tolerability
11%
Comprehensive Assessment
11%
Cochrane
11%
Positive Outcomes
11%
Progression-free Survival
11%
Prostate Cancer
11%
Oncologic
11%
Clinical Efficacy
11%
Event Response
11%
Chemotherapy Drugs
11%
Solid Tumor Therapy
11%
FDA-approved Drugs
11%
Drug Indications
11%
Data Screening
11%
Adult Participants
11%
Survival Response
11%
Median Progression-free Survival
11%
Off-label Indications
11%
Drug Manufacturer
11%
Novel Chemotherapy
11%
RECIST Criteria
11%
Complete Analysis
11%
Drug Risk
11%
PSA Response
11%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Drug Development
100%
Enzalutamide
100%
Adverse Event
33%
Progression Free Survival
22%
Overall Survival
22%
Solid Malignant Neoplasm
22%
Chemotherapy
11%
Tolerability
11%
Prostate Cancer
11%
Pharmaceutical Manufacturing
11%